The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2)

Journal of Dermatology

Volumn 26, Issue 11, 1999, Pages 738-747

  Manga, Prashiela ^b   Orlow, Seth J ^a   Perelman, Ronald O ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

OCA2; Oculocutaneous albinism; Pink eyed dilution

Indexed keywords

CARRIER PROTEIN; MELANIN; MONOPHENOL MONOOXYGENASE;

ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 15Q; DISEASE ASSOCIATION; GENE DELETION; GENE ISOLATION; GENE LOCUS; HAPPY PUPPET SYNDROME; HUMAN; MELANOGENESIS; MISSENSE MUTATION; NONHUMAN; OCULOCUTANEOUS ALBINISM; PHENOTYPE; PRADER WILLI SYNDROME;

EID: 0033390217     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02085.x     Document Type: Article

References (80)

1. Durham FM: On the presence of tyrosinases in the skins of some pigmented vertebrates, Proc R Soc (Lond), 74: 310-313, 1904.
2. Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S: Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene, Biochem biophys Res Commun, 164: 990-996, 1989.
3. Oetting WS, King RA: Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: Mutations and polymorphisms of the human tyrosinase gene, Hum Mutat, 2: 1-6, 1993.
4. Shimano K: Partial purification and kinetic studies of mammalian tyrosinase, Biochem Biophys Acta, 62: 205-215, 1962.
5. Tripathi RK, Hearing VJ, Urabe K, Aroca P, Spritz RA: Mutational mapping of the catalytic activities of human tyrosinase, J Biol Chem, 267: 23707-23712, 1992.
6. Kugelman TP, Van Scott EJ: Tyrosinase activity in melanocytes of human albinos, J Invest Dermatol, 37: 73-76, 1968.
7. Witkop CJJ, Quevedo WCJ, Fitzpatrick TB, King RA: Albinism, in Scrier CA, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease, McGraw Hill, New York, 1989, pp 2905-2947.
8. Witkop CJJ, Quevedo WCJ, Fitzpatrick TB: Albinism and other disorders of pigment metabolism, in Stanbury J, Wyngerden JB, Fredrickson DS, Goldstein JL, Brown MS (eels): The Metabolic Basis of Inherited Disease, McGraw Hill, New York, 1983, pp 301-346.
9. Giebel LB, Tripathi RK, Strunk KM: Tyrosinase gene mutations associated with type 1B ("yellow") oculocutaneous albinism, Am J Hum Genet, 48: 1159-1167, 1991.
10. Spritz RA, Oh J, Fukai K: Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1), Hum 'Mutat, 10: 171-174, 1997.
11. ) King RA, Mentink MM, Oetting WS: Albinism, in Scriver CR, Beaudet AL, Sly WS, Valle DV (eds): The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1995, pp 4353-4392.
12. Kromberg JG, Jenkins T: Prevalence of albinism in the South African negro, S Afr Med J, 61: 383-386, 1982.
13. Ramsay M, Colman MA, Stevens G: The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12, Am J Hum Genet, 51: 879-884, 1992.
14. Brilliant MH, Gondo Y, Eicher EM: Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning, Science, 252: 566-569, 1991.
15. Brilliant MH: The mouse pink-eyed dilution locus: A model for aspects of Prader-Willi syndrome, Angelman syndrome, and a form of hypomelanosis of Ito, Mamm Genome, 3: 187-191, 1992.
16. Nicholls RD: A cDNA from proximal human chromosome 15q maps near Mtv-1 on mouse chromosome 7, Mouse Newsletter, 84: 8, 1989.
17. Lee ST, Nicholls RD, Schnur RE: Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2), Hum Mol Genet, 3: 2047-2051, 1994.
18. Manga P, Kromberg JG, Box NF, Sturm RA, Jenkins T, Ramsay M: Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene, Am J Hum Genet, 61: 1095-1101, 1997.
19. Lee ST, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA: Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism, N Engl J Med, 330: 529-534, 1994.
20. Gardner JM, Nakatsu Y, Gondo Y: The mouse pink-eyed dilution gene: Association with human Prader-Willi and Angelman syndromes, Science, 257: 1121-1124, 1992.
21. Rinchik EM, Bultman SJ, Horsthemke B: A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism, Nature, 361: 72-76, 1993.
22. Sviderskaya EV, Bennett DC, Ho L, Bailin T, Lee ST, Spritz RA: Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human p cDNA, and defective complementation by OCA2 mutant sequences, J Invest Dermatol, 108: 30-34, 1997.
23. Durham-Pierre D, Gardner JM, Nakatsu Y: African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism, Nat Genet, 7: 176-179, 1994.
24. Stevens G, van Beukering J, Jenkins T, Ramsay M: An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids, Am J Hum Genet, 56: 586-591, 1995.
25. Spritz RA, Fukai K, Holmes SA, Luande J: Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2), Am J Hum Genet, 56: 1320-1323, 1995.
26. Stevens G, Ramsay M, Jenkins T: Oculocutaneous albinism (OCA2) in sub-Saharan Africa: Distribution of the common 2.7-kb P gene deletion mutation, Hum Genet, 99: 523-527, 1997.
27. Russell ES: A quantitative histological study of the pigment found in the coat-colour mutants of the house-mouse. IV. The nature of the genie effects of five major allelic series, Genetics, 34: 146-166, 1949.
28. Bothwell J: Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: A study in black South Africans, Int J Dermatol, 36: 831-836, 1997.
29. Kromberg JG, Castle D, Zwane EM, Jenkins T: Albinism and skin cancer in Southern Africa, Clin Genet, 36: 43-52, 1989.
30. un and p′ alleles of the pink-eyed dilution locus, Mamm Genome, 7: 315-316, 1996.
31. Gondo Y, Gardner JM, Nakatsu Y: High-frequency genetic reversion mediated by a DNA duplication: The mouse pink-eyed unstable mutation, Proc Natl Acad Sci USA, 90: 297-301, 1993.
32. Yakubu A, Mabogunje OA: Skin cancer in African albinos, Acta Oncol, 32: 621-622, 1993.
33. Schulze KE, Rapini RP, Duvic M: Malignant melanoma in oculocutaneous albinism, Arch Dermatol, 125: 1583-1586, 1989.
34. Ihn H, Nakamura K, Abe M: Amelanotic metastatic melanoma in a patient with oculocutaneous albinism, J Am Acad Dermatol, 28: 895-900, 1993.
35. Lund RD: Uncrossed visual pathways of hooded and albino rats, Science, 149: 1506-1507, 1965.
36. Witkop CJJ, Jay B, Creel D, Guillery RW: Optic and otic neurologic abnormalities in oculocutaneous and ocular albinism, Birth Defects: Original Article Series, 18: 299-318, 1982.
37. Creel DJ, Giolli RA: Retinogeniculostriate projections in guinea pigs: Albino and pigmented strains compared, Exp Neurol, 36: 411-425, 1972.
38. Guillery RW, Kaas JH: A study of normal and congenitally abnormal retino-geniculate projections in cats, J Comp Neurol, 187: 313-348, 1971.
39. Apkarian P, Reits D, Spekreijse H, Van Dorp D: A decisive electrophysiological test for human albinism, Electroencephalogr Clin Neurophysiol, 55: 513-531, 1983.
40. Witkop CJ Jr: Albinism, Adv Hum Genet, 2: 61-142, 1971.
41. Guillery RW: Neural abnormalities of albinos, Trends in Neurosci, 8: 364-367, 1986.
42. Creel DJ, Summers CG, King RA: Visual anomalies associated with albinism, Ophthalmic Paediatr Genet, 11: 193-200, 1990.
43. Sidman RL, Pearlstein R: Pink-eyed dilution (p) gene in rodents: Increased pigmentation in tissue culture, Dev Biol, 12: 93-116, 1965.
44. Rosemblat S, Sviderskaya E, Easty DJ: Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: Correction by culture in the presence of excess tyrosine, Exp Cell Res, 239: 344-352, 1998.
45. Lee ST, Nicholls RD, Jong MT, Fukai K, Spritz RA: Organization and sequence of the human P gene and identification of a new family of transport proteins, Genomics, 26: 354-363, 1995.
46. Rosemblat S, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ: Identification of a melanosomal membrane protein encoded by the pink eyed dilution (type II oculocutaneous albinism) gene. Proc Natl Acad Sci USA, 91: 12071-12075, 1994.
47. Potterf SB, Muller J, Bernadini I: Characterization of a melanosomal transport system in marine melanocytes mediating entry of the melanogenic substrate tyrosine, J Biol Chem, 271: 4002-4008, 1996.
48. Wang H, Kavanaugh MP, North RA, Rabat D: Cell-surface receptor for ecotropic marine retroviruses is a basic amino-acid transporter, Nature, 352: 729-731, 1991.
49. Gahl WA, Potterf B, Durhampierre D, Brilliant MH, Hearing VJ: Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes, Pigment Cell Res, 8: 229-233, 1995.
50. Potterf SB, Furumura M, Sviderskaya EV, Santis C, Bennett DC, Hearing VJ: Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes, Exp Cell Res, 244: 319-326, 1998.
51. Bhatnagar V, Anjaiah S, Puri N, Darshanam BA, Ramaiah A: pH of melanosomes of B16 murine melanoma is acidic: Its physiologic importance in the regulation of melanin biosynthesis, Arch Biochem Biophys, 307: 183-192, 1993.
52. Puri N, Brilliant M: The function of the pink-eyed dilution protein, Pigment Cell Res, 11: 174, 1998.
53. Lamoreux ML, Zhon BK, Rosemblat S, Orlow SJ: The pink-eyed dilution protein and the eumelanin/pheomelanin switch: In support of a unifying hypothesis, Pigment Cell Res, 8: 263-270, 1995.
54. Prota G, Lamoreux ML, Muller J: Comparative analysis of melanins and melanosomes produced by various coat color mutants, Pigment Cell Res, 8: 153-163, 1995.
55. Tamate HB, Hirobe T, Wakamatsu K, Ito S, Shibahara S, Ishikawa K: Levels of tyrosinase and its mRNA in coat-color mutants of C57BL/10J congenic mice: Effects of genic substitution at the agouti, brown, albino, dilute, and pink-eyed dilution loci, J Exp Zool, 250: 304-311, 1989.
56. un) mutation, Exp Eye Res, 57: 301-305, 1993.
57. Orlow SJ, Brilliant MH: The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye, Exp Eye Res, 68 147-154, 1999.
58. Orlow SJ, Zhou BK, Chakraborty AK, Drucker M, Pifko-Hirst S, Pawelek JM: High-molecular weight forms of tyrosinase and the tyrosinase-related proteins: Evidence for a melanogenic complex, J Invest Dermatol, 103: 196-201, 1994.
59. Lamoreux ML: Dopachrome conversion and dopa oxidase activities in recessive yellow mice. Catalytic activities of extracts from pheomelanic and eumelanic tissues, J Hered, 77: 337-340, 1986.
60. Nakatsu Y, Tyndale RF, deLorey TM: A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus, Nature, 364: 448-450, 1993.
61. Lamoreux ML, Pendergast P: Genetic controls over melanocyte differentiation: Interaction of agouti-locus and albino-locus, J Exp Zool, 243: 71-79, 1987.
62. Moyer FH: Genetic variations in the fine structure and ontogeny of mouse melanin granules, Am Zool, 6: 43-66, 1966.
63. Rittenhouse E: Genetic effects on fine structure and development of pigment granules in mouse hair bulb melanocytes II. The c and p loci, and ddpp interaction, Dev Biol, 17: 366-381, 1968.
64. King RA, Creel D, Cervenka J, Okoro AN, Witkop CJ: Albinism in Nigeria with delineation of new recessive oculocutaneous type. Clin Genet, 17: 259-270, 1980.
65. Kromberg JGR: A genetic and psychosocial study of albinism in southern Africa, PhD thesis, University of the Witwatersrand, Johannesburg, 1985.
66. Manga P: Identification and molecular characterization of the genes for brown and rufous oculocutaneous albinism in southern Africa, PhD thesis, University of the Witwatersrand, Johannesburg, 1997.
67. Butler MG: Hypopigmentation: A common feature of Prader-Labhart-Willi syndrome, Am J Hum Genet, 45: 140-146, 1989.
68. Hamabe J, Fukushima Y, Harada N: Molecular study of the Prader-Willi syndrome: Deletion, RFLP, and phenotype analyses of 50 patients, Am J Med Genet, 41: 54-63, 1991.
69. Fryburg JS, Breg WR, Lindgren V: Diagnosis of Angelman syndrome in infants. Am J Med Genet, 38: 58-64, 1991.
70. Dickinson AJ, Fielder AR, Young ID, Duckett DP: Ocular findings in Angelman's (happy puppet) syndrome, Ophthalmic Paediatr Genet, 11: 1-6, 1990.
71. Roberts DF, Kromberg JGR, Jenknis T: Differentiation of heterozygotes in recessive albinism, J Med Genet, 23: 323-327, 1986.
72. Spritz RA, Bailin T, Nicholls RD: Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele, Am J Med Genet, 71: 57-62, 1997.
73. Sybert VP: Hypomelanosis of Ito, Pediatr Dermatol, 7: 74-76, 1990.
74. Nehal KS, PeBenito R, Orlow SJ: Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko, Arch Dermatol, 132: 1167-1170, 1996.
75. Loomis CA, Orlow SJ: Cutaneous findings in mosaicism and chimerism, Current Problems in Dermatology, 3: 87-92, 1996.
76. Pellegrino JE, Schnur RE, Kline R, Zackai EH, Spinner NB: Mosaic loss of 15q11q13 in a patient with hypomelanosis of Ito: Is there a role for the P gene?, Hum Genet, 96: 485-489, 1995.
77. Allison AC: Protection afforded by sickle cell trait against subtertian malarial infection, BMJ, 1: 290-294, 1954.
78. Oskam L, Hartskeerl RA, Hermans CJ: A 46 kDa integral membrane protein from Mycobacterium leprae resembles a number of bacterial and mammalian membrane transport proteins, Microbiology, 141: 1963-1968, 1995.
79. Luanda J, Henschke CI, Mohammed N: The Tanzanian human albino skin. Natural history, Cancer, 55: 1823-1828, 1985.
80. Okoro AN: Albinism in Nigeria, Br J Dermatol, 92: 485-492, 1975.